In ovalbumin‐MC38 colon tumor bearing mice, subcutaneously injected nanovaccine remarkably inhibited the tumor growth through activating ovalbumin‐specific CD8+ T cells mediated immune responses and alleviating the immunosuppressive tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.